title: Deciding on a combination of anticoagulant and antiplatelet drugs.
abstract: Patients being treated for atrial fibrillation may develop cardiovascular disease before or after the onset of their heart rhythm problem, and may require a combination of antiplatelet and anticoagulant drugs. This article describes the evidence for the combinations used to treat acute coronary syndrome in patients with atrial fibrillation.
authors.affiliation: Foundation Doctor in the Department of Medicine, Salford Royal Foundation Trust, Salford.
authors.forename: Mohammad
authors.initials: M
authors.lastname: Moatari
authors.affiliation: NIHR Clinical Lecturer in Cardiac Electrophysiology in the Department of Cardiovascular Sciences, University of Manchester, Manchester.
authors.forename: Graeme
authors.initials: G
authors.lastname: Kirkwood
authors.affiliation: Consultant in the Department of Haematology, Central Manchester University Hospitals NHS Foundation Trust, Manchester Royal Infirmary, Manchester M13 9WL.
authors.forename: Jecko
authors.initials: J
authors.lastname: Thachil
mesh_terms: D054058:Acute Coronary Syndrome / Q000150:complications* / Q000188:drug therapy*; D000465:Algorithms; D000925:Anticoagulants / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy*; D004334:Drug Administration Schedule; D006801:Humans; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors